GlaxoSmithKline
GSK
#217
Rank
A$143.63 B
Marketcap
A$71.11
Share price
-2.48%
Change (1 day)
31.51%
Change (1 year)

GlaxoSmithKline (GSK) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$92.19 Billion

According to GlaxoSmithKline's latest financial reports the company's total liabilities are A$92.19 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

GlaxoSmithKline - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$93.56 B8.28%
2023-12-31A$86.41 B-2.89%
2022-12-31A$88.97 B-17.26%
2021-12-31A$107.54 B1.75%
2020-12-31A$105.69 B-7.99%
2019-12-31A$114.87 B17.21%
2018-12-31A$98.01 B7.04%
2017-12-31A$91.56 B-1.16%
2016-12-31A$92.63 B2.18%
2015-12-31A$90.66 B33.44%
2014-12-31A$67.94 B7.2%
2013-12-31A$63.38 B17.29%
2012-12-31A$54.03 B10.53%
2011-12-31A$48.89 B-0.97%
2010-12-31A$49.36 B-14.68%
2009-12-31A$57.86 B-10.37%
2008-12-31A$64.55 B34.55%
2007-12-31A$47.97 B21.44%
2006-12-31A$39.50 B-14.57%
2005-12-31A$46.24 B13.04%
2004-12-31A$40.91 B9.75%
2003-12-31A$37.27 B-12.32%
2002-12-31A$42.51 B10.29%
2001-12-31A$38.54 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AstraZeneca
AZN
A$103.02 B 11.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
A$173.94 B 88.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$116.79 B 26.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$94.07 B 2.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$99.32 B 7.74%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
A$49.04 B-46.80%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
A$0.62 B-99.33%๐Ÿ‡บ๐Ÿ‡ธ USA